Fiera Capital Corp Sells 8,078 Shares of Option Care Health, Inc. $OPCH

Fiera Capital Corp cut its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 1.2% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 642,372 shares of the company’s stock after selling 8,078 shares during the quarter. Fiera Capital Corp owned about 0.40% of Option Care Health worth $20,864,000 as of its most recent SEC filing.

Several other hedge funds have also added to or reduced their stakes in OPCH. US Bancorp DE increased its holdings in shares of Option Care Health by 5.0% in the first quarter. US Bancorp DE now owns 8,199 shares of the company’s stock valued at $287,000 after purchasing an additional 393 shares during the last quarter. Assetmark Inc. grew its stake in Option Care Health by 1.6% in the 2nd quarter. Assetmark Inc. now owns 26,690 shares of the company’s stock valued at $867,000 after buying an additional 416 shares during the last quarter. Sheets Smith Wealth Management raised its holdings in Option Care Health by 1.9% in the 2nd quarter. Sheets Smith Wealth Management now owns 24,938 shares of the company’s stock valued at $810,000 after acquiring an additional 457 shares during the period. Louisiana State Employees Retirement System raised its holdings in Option Care Health by 1.1% in the 1st quarter. Louisiana State Employees Retirement System now owns 47,700 shares of the company’s stock valued at $1,667,000 after acquiring an additional 500 shares during the period. Finally, Nisa Investment Advisors LLC lifted its position in Option Care Health by 20.7% during the second quarter. Nisa Investment Advisors LLC now owns 3,701 shares of the company’s stock worth $120,000 after acquiring an additional 635 shares during the last quarter. Institutional investors and hedge funds own 98.05% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on the company. Barrington Research reaffirmed an “outperform” rating and issued a $38.00 target price on shares of Option Care Health in a research report on Friday, October 31st. TD Cowen reduced their price target on Option Care Health from $30.00 to $27.00 and set a “hold” rating for the company in a research note on Monday, November 3rd. Morgan Stanley initiated coverage on Option Care Health in a report on Friday, October 17th. They issued an “overweight” rating and a $35.00 price objective on the stock. Weiss Ratings reissued a “hold (c)” rating on shares of Option Care Health in a report on Wednesday, October 8th. Finally, Cowen began coverage on shares of Option Care Health in a research note on Thursday, October 2nd. They issued a “hold” rating on the stock. Nine equities research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $35.67.

Option Care Health Price Performance

Shares of NASDAQ OPCH opened at $28.83 on Friday. The business has a fifty day moving average price of $27.78 and a two-hundred day moving average price of $29.63. The stock has a market capitalization of $4.58 billion, a PE ratio of 23.06, a P/E/G ratio of 1.74 and a beta of 0.88. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.52 and a quick ratio of 1.00. Option Care Health, Inc. has a fifty-two week low of $21.39 and a fifty-two week high of $35.53.

Insider Buying and Selling

In other news, Director Timothy P. Sullivan bought 20,000 shares of the company’s stock in a transaction dated Thursday, August 21st. The stock was bought at an average cost of $27.51 per share, for a total transaction of $550,200.00. Following the transaction, the director owned 49,229 shares of the company’s stock, valued at $1,354,289.79. This represents a 68.43% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Harry M. Jansen Kraemer, Jr. purchased 38,000 shares of the business’s stock in a transaction dated Monday, November 3rd. The shares were purchased at an average cost of $25.98 per share, with a total value of $987,240.00. Following the acquisition, the director owned 413,390 shares in the company, valued at $10,739,872.20. This trade represents a 10.12% increase in their position. The disclosure for this purchase is available in the SEC filing. Insiders bought 97,411 shares of company stock valued at $2,614,816 over the last quarter. 0.64% of the stock is owned by company insiders.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.